Teva Wins FDA Approval for Monthly Schizophrenia Injection Weltruza
Weltruza FDA approval gives Teva a once-monthly subcutaneous olanzapine injection for adults with schizophrenia. Doses, trial data, safety, launch.
Category: Pharmaceuticals
Stay informed with the latest updates and insights on pharmaceuticals at Med Pharma News. Explore breaking news, industry trends, research advancements, and regulatory developments shaping the pharmaceutical landscape.
Read More
WHO Launches Global Roadmap to Tackle Hypertension in Pregnancy
Hypertension in pregnancy is linked to about 42,000 maternal deaths a year. What the new WHO global roadmap covers and what is missing.
Change Lifestyle Before Giving Children Weight-Loss Medication, WHO Says
WHO childhood obesity guidelines rule out weight-loss drugs under 10 and put lifestyle care before medicine for teens. What families should know.
AnnJi Advances AJ201 into Phase 3 Trial for Kennedy’s Disease
AJ201 (rosolutamide) moves into the pivotal Phase 3 ROMA-KD trial for Kennedy disease, or SBMA. Mechanism, earlier data and what is unknown.
AAVantgarde Reports Updated Gene Therapy Data for Usher Syndrome and Stargardt Disease
AAVantgarde reports early AAVB-081 results in Usher 1B (7 of 12 gained a line of vision) and preclinical AAVB-039 data for Stargardt disease.
Genmab Reports Positive Rina-S Data in Platinum-Resistant Ovarian Cancer
Genmab reports a 45.9% response rate and 12.1-month response duration for Rina-S in platinum-resistant ovarian cancer. Data, safety and what is next.
Samfara Makes Debut Buyout With Danish API Maker Chr. Olesen Synthesis
Samfara buyout: the London firm made its first investment, backing Danish controlled-substance API maker Chr. Olesen Synthesis. Terms and risks.
AstraZeneca, Daiichi Sankyo and Summit Build a Cost-Sharing Cancer Trial Pact Around Datroway and Ivonescimab
The Datroway ivonescimab pact links AstraZeneca, Daiichi Sankyo and Summit in a cost-sharing trial deal. How it works and what it signals for oncology.
TIL Healthcare Pharma Plant Blast in Andhra Pradesh’s Sri City Leaves Workers Dead and Injured
TIL Healthcare Sri City blast: a boiler explosion at the Andhra Pradesh plant killed five workers and injured over 10 on 3 October; cause under probe.